Cargando…
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
The development of COVID-19 syndrome in anticoagulated patients, and especially their admission to intensive-care units with acute severe respiratory syndrome (SARS-CoV-2), expose them to specific problems related to their therapy, in addition to those associated with the acute viral infection. Pati...
Autores principales: | Testa, Sophie, Paoletti, Oriana, Giorgi-Pierfranceschi, Matteo, Pan, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157827/ https://www.ncbi.nlm.nih.gov/pubmed/32297089 http://dx.doi.org/10.1007/s11739-020-02331-1 |
Ejemplares similares
-
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases
por: Poli, Daniela, et al.
Publicado: (2020) -
Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study
por: Giorgi-Pierfranceschi, Matteo, et al.
Publicado: (2020) -
SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020) -
Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic
por: Lavorini, Federico, et al.
Publicado: (2021) -
Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines
por: Marcucci, Rossella, et al.
Publicado: (2021)